Histopathological characterization of magnetic resonance imaging- detectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus)

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 649-663

  'T Hart, Bert A ^a   Bauer, Jan ^b   Muller, Henk Jan ^c   Melchers, Bert ^d   Nicolay, Klaas ^c   Brok, Herbert ^a   Bontrop, Ronald E ^a   Lassmann, Hans ^b   Massacesi, Luca ^e  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d TNO   (Netherlands)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HISTOPATHOLOGY; MALE; MARMOSET; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMATE; PRIORITY JOURNAL; REMYELINIZATION; WHITE MATTER;

EID: 0031858641     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65606-4     Document Type: Article

References (32)

1. Adams CWM: The general pathology of multiple sclerosis: morphological and chemical aspects of the lesions. Multiple Sclerosis: Diagnosis and Management. Edited by JF Hallpike, CWM Adams, WW Toutelotte. London, Chapman and Hall, 1983
2. Thorpe JW, Miller DH. MRI: its implication and impact. Int Mult Scler J 1994, 1:7-15
3. Young IR, Hall AS, Pallis CA: Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981, 2:1063-1066
4. McFarland HF: Clinical trials in multiple sclerosis. Controlled Clinical Trials in Neurological Disease. Edited by RJ Porter, BS Schoenberg. Boston, Kluwer Academic, 1990, pp 321-341
5. Harris JO, Frank JA, Patronas NJ, McFarlin DE, McFarland HF: Serial Gd-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991, 29:548-555
6. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DPE, McDonald WI: Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991, 29:53-62
7. Barkhof F, Scheltens P, Frequin STFM, Nauta JJP, Tas MW, Valk J, Hommes OR: Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs. clinical findings in determining disease activity. Am J Roentgenol 1992, 159:1041-1047
8. Van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin STFM, Valk J: Correlating MRI, and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short TE (T1-weighed) spin-echo images. Neurology 1995, 45:1684-1690
9. Hawkins CP, Munro PMG, MacKenzie F, Kesselring J, Tofts PS, du Boulay EPGH, Landon DN, McDonald WI: Duration and selectivity of blood-brain-barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by Gd-DTPA and protein markers. Brain 1990, 13:365-378
10. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV: In vivo MRI, and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: quantitation of inflammation and oedema. Brain 1996, 119:239-248
11. Quint DJ, Buckham SP, Bolton EJ, Solari R, Champion BR, Zanders ED: Immunoregulation in the common marmoset, Callithrix jacchus: functional properties of T and B lymphocytes and their response to human interleukins 2 and 4. Immunology 1990, 69:616-621
12. Neubert R, Nogueira AC, Neubert D: Thalidomide derivatives and the immune system. 1. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood. Arch Toxicol 1993, 67:1-17
13. Neubert R, Foerster M, Nogueira AC, Helge H: Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset. Life Sci 1995, 15:317-324
14. Bontrop RE, Otting N, Slierendregt BL, Lanchbury JS: Evolution of major histocompatibility complex polymorphisms and T cell receptor diversity in primates. Immunol Rev 1995, 143:33-62
15. Uccelli A, Oksenberg JR, Jeong M, Genain CP, Rombos T, Jaeger EEM, Giunti D, Lanchbury JS, Hauser SL: Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. J Immunol 1997, 158:1201-1207
16. Van Noort JM, El Ouagmir M, Boon J, Van Seghel AC: Fractionation of central nervous system myelin proteins by reversed phase high performance liquid chromatography. J Chromatogr 1994, 653:155-161
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
18. Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL: Actively and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995, 37:519-530
19. Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL: In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 1994, 94:1339-1345
20. Van Lambalgen R, Jonker M: Experimental allergic encephalomyelitis in rhesus monkeys: 1. Immunological parameters in EAE-resistant and susceptible rhesus monkeys. Clin Exp Immunol 1985, 68:100-107
21. Slierendregt BL, Hall M, 't Hart BA, Otting N, Anholts J, Verduyn W, Lanchbury JS, Bontrop RE: Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. Int Immunol 1995, 7:1671-1679
22. Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJP: Gadopentetate diglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T. Am J Neuroradiol 1992, 13:1257-1259
23. Laman JD, Van Meurs M, Schellekens MM, De Boer M, Massacesi L, Melchers B, Lassmann H, Claassen E, 't Hart BA: Expression of accessory molecules and cytokines in acute experimental autoimmune encephalomyelitis (EAE) in marmoset monkeys (Callithrix jacchus). J Neuroimmunol 1998, 86:30-45
24. Vass K, Lassmann H, Wekerle H, Wisniewski HM: The distribution of la-antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 1996, 70:149-160
25. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H: Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996, 6:259-274
26. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C: The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 1993, 143:555-564
27. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar A, Lassmann H: Monocyte/Macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995, 38:788-796
28. Nagara H, Inoue T, Koga T, Kitaguchi T, Tateishi J, Goto I: Formalin-fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci 1987, 81:67-77
29. Barkhof F, Scheltens PH, Kamphorst W: Pre-and postmortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer's disease. J Neurol Sci 1993, 117:175-178
30. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H: Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann Neurol 1998, 43:465-471
31. Barkhof F: Imaging of remyelination. Mult Scler 1997, 3:129-132
32. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H: Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994, 117:1311-1322